Brand semaglutide
Sold by Aspire Health · Injection · device not recorded · every brand semaglutide record
The program identifies an injection, but the delivery device has not been established.
Price
| Term | Published rate | Charged today |
|---|---|---|
| Wegovy 0.25 mg; insurance-dependent listed price Price conditions have not been established; the quoted figure is not a verified recurring rate. Public table says pricing varies by insurance; this is not a verified universal cash bill. Required care is separate. “0.25 mg 4 weeks $199” | $199Published figure | Charged todayNot verified |
| Wegovy 0.5 mg; insurance-dependent listed price Price conditions have not been established; the quoted figure is not a verified recurring rate. Public table says pricing varies by insurance; this is not a verified universal cash bill. Required care is separate. “0.5 mg 4 weeks $199” | $199Published figure | Charged todayNot verified |
| Wegovy ALL OTHER DOSES; insurance-dependent listed price Price conditions have not been established; the quoted figure is not a verified recurring rate. Public table says pricing varies by insurance; this is not a verified universal cash bill. Required care is separate. “ALL OTHER DOSES 4 weeks $399” | $399Published figure | Charged todayNot verified |
Price sources
- Wegovy 0.25 mg; insurance-dependent listed price · aspirehealth.care — read October 2026
- Wegovy 0.5 mg; insurance-dependent listed price · aspirehealth.care — read October 2026
- Wegovy ALL OTHER DOSES; insurance-dependent listed price · aspirehealth.care — read October 2026
We earn nothing from this link. It opens Aspire Health's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Strive Pharmacy / Boudreaux’s New Drug Store / Rush Pharmacy (publicly listed network; individual assignment unconfirmed) |
|---|---|
| States | Not disclosed |
| Prescriber | Both |
| Cancellation | Cancel care by emailing info@aspirehealth.care; cancellation takes effect at the end of the paid billing cycle, without partial-period refunds except as required by law. Consultation services are generally nonrefundable after clinical review, including denial of a requested treatment. The medication-ordering FAQ makes compounded charges nonrefundable once the prescription is sent to the pharmacy, while general terms describe final medication sales after shipment, with stated error exceptions. Cancel auto-refills before renewal or switch to manual refills. https://aspirehealth.care/faq/ |
| Membership | Required. $49 every 28 days. The FAQ explicitly requires $49 every 28 days for Weight Management, starting at enrollment, separately from medication. The main page calls it $49 Monthly Medical Care; its generic monthly wording is not used to convert the specific 28-day cycle into a calendar month. https://aspirehealth.care/faq/ https://aspirehealth.care/weight-loss/ |
| Consult fee | None. “The actual main weight-management page explicitly advertises a free new-patient consultation. Ongoing medical care and medication are separately charged; this does not claim all later services are free.” |
Recorded from aspirehealth.care. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Aspire Health states two different, unreconciled monthly non-medication fees: the semaglutide and tirzepatide product pages each say 'Monthly Medical Care: $49 — Includes provider visits, messaging, prescription management, and ongoing medical support. Medication priced separately (see tables above)', while the FAQ separately describes a 'LoseIt Program' at $75/month whose active enrollment 'is required to continue medication therapy.' Neither page mentions or reconciles the other figure. The membership entry above uses the $75 LoseIt Program figure since it is the one explicitly tied to required enrollment; the $49 'Monthly Medical Care' quote ('Monthly Medical Care: $49') from https://aspirehealth.care/tirzepatide-for-weight-loss/ and https://aspirehealth.care/semaglutide-for-medical-weight-management/ is flagged here rather than recorded a second time. Separately, https://aspirehealth.care/service-areas/ lists 49 state names (every state except Alabama) grouped as 'Western/Central/Eastern States,' but the page explains these are color-coded on an interactive map as 'Currently Licensed' vs. 'Coming Soon' — this text-extraction tool cannot read the map's color-coding, so which of the 49 are actually served today could not be confirmed; states.list is left empty rather than asserting all 49 as current coverage. The Wegovy/Zepbound dose tables are captioned 'Pricing varies based on insurance coverage. Patients should verify benefits directly with their insurance provider,' so it is unclear whether the listed dollar figures are a cash-pay price or already insurance-adjusted; recorded as-is with that caveat rather than labeled 'cash price'.
- 2. October 2026 — Wegovy is an actual named prescribing option. Its dose table describes four-week supplies, but explicitly says pricing varies with insurance; no universal cash invoice is established. The catalog also lists Ozempic as weekly injectable semaglutide. Neither current public source establishes a dispensed device. https://aspirehealth.care/weight-loss-medications/
- 3. October 2026 — Required care is $49 every 28 days, separately from medication. The current FAQ replaces the older $75/month figure. The public pharmacy list names Strive Pharmacy, Boudreaux’s New Drug Store and Rush Pharmacy (Florida and Texas locations); it does not establish which will fill a particular prescription. The fully loaded service map identifies licensed versus coming-soon states by color. A conservative affirmative subset of 31 clearly blue states is recorded; small ambiguous labels are not asserted. https://aspirehealth.care/faq/ https://aspirehealth.care/service-areas/
- 4. October 2026 — The main weight-loss page explicitly advertises a free new-patient consultation and $49 Monthly Medical Care, while the FAQ states $49 every 28 days. The exact FAQ cycle is retained; a 28-day cycle is not a calendar month. General legal language about consultation fees does not override the explicit free initial consultation offer. https://aspirehealth.care/weight-loss/ https://aspirehealth.care/faq/
- 5. October 2026 — The fully loaded public map marks these 31 clearly identifiable states blue under its Currently Licensed legend: Alaska, Arizona, Colorado, Florida, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Dakota, Oklahoma, South Dakota, Utah, Vermont, Virginia, Washington, Wisconsin, Wyoming. This is a conservative licensure subset, not an exhaustive roster or confirmation that this medication is available in each state. Tiny Delaware, Maryland and District of Columbia markings were not classified. Drug, provider and pharmacy restrictions still apply; full program coverage is not established. https://aspirehealth.care/service-areas/
7 further notes concern other Aspire Health programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.